AXA lowered its position in Dow Chemical (NYSE:DWDP) by 5.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,156,202 shares of the company’s stock after selling 69,817 shares during the quarter. AXA’s holdings in Dow Chemical were worth $82,345,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the company. Alliancebernstein L.P. increased its stake in shares of Dow Chemical by 8.5% during the fourth quarter. Alliancebernstein L.P. now owns 11,347,134 shares of the company’s stock valued at $808,143,000 after purchasing an additional 888,106 shares in the last quarter. Bluestein R H & Co. increased its stake in shares of Dow Chemical by 233.1% during the fourth quarter. Bluestein R H & Co. now owns 43,086 shares of the company’s stock valued at $3,069,000 after purchasing an additional 30,150 shares in the last quarter. Delpha Capital Management LLC bought a new stake in shares of Dow Chemical during the fourth quarter valued at approximately $122,000. Corient Capital Partners LLC increased its position in shares of Dow Chemical by 6.8% during the fourth quarter. Corient Capital Partners LLC now owns 19,355 shares of the company’s stock valued at $1,378,000 after acquiring an additional 1,224 shares in the last quarter. Finally, 180 Wealth Advisors LLC bought a new stake in shares of Dow Chemical during the fourth quarter valued at approximately $542,000. 70.45% of the stock is currently owned by hedge funds and other institutional investors.
In related news, General Counsel Charles J. Kalil sold 69,400 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $72.66, for a total value of $5,042,604.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Ronald C. Edmonds sold 15,000 shares of the business’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $71.83, for a total transaction of $1,077,450.00. The disclosure for this sale can be found here. Insiders own 0.42% of the company’s stock.
Shares of DWDP traded down $1.73 during trading on Friday, reaching $63.71. 11,325,014 shares of the company traded hands, compared to its average volume of 10,102,218. Dow Chemical has a twelve month low of $59.29 and a twelve month high of $77.08. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.91 and a quick ratio of 1.26. The stock has a market cap of $148,382.05, a PE ratio of 18.74, a P/E/G ratio of 1.62 and a beta of 1.31.
Dow Chemical (NYSE:DWDP) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.16. The company had revenue of $20.07 billion for the quarter, compared to analysts’ expectations of $19.46 billion. Dow Chemical had a net margin of 2.34% and a return on equity of 8.21%. The company’s revenue was up 54.1% on a year-over-year basis. sell-side analysts expect that Dow Chemical will post 4.14 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, March 15th. Stockholders of record on Wednesday, February 28th were issued a $0.38 dividend. The ex-dividend date was Tuesday, February 27th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 2.39%. Dow Chemical’s payout ratio is 44.71%.
Several equities research analysts recently issued reports on DWDP shares. ValuEngine upgraded shares of Dow Chemical from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Zacks Investment Research upgraded shares of Dow Chemical from a “hold” rating to a “buy” rating and set a $85.00 target price on the stock in a report on Tuesday, January 30th. Barclays upgraded shares of Dow Chemical from an “underweight” rating to an “equal weight” rating in a research report on Wednesday, January 31st. Nomura boosted their target price on shares of Dow Chemical from $83.00 to $84.00 and gave the stock a “buy” rating in a report on Friday, February 2nd. Finally, Jefferies Group restated a “buy” rating and issued a $85.00 target price on shares of Dow Chemical in a report on Friday, February 2nd. Six equities research analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $80.77.
TRADEMARK VIOLATION WARNING: “Axa Sells 69,817 Shares of Dow Chemical (DWDP)” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/08/dowdupont-inc-dwdp-shares-sold-by-axa.html.
Dow Chemical Company Profile
DowDuPont Inc, through its subsidiaries, engages in agriculture, materials science, and specialty products businesses worldwide. The company's Agriculture segment develops and sells hybrid corn seed and soybean seed varieties; canola, cotton, sunflower, sorghum, wheat, and rice seeds; silage inoculants; and weed control, disease control, and insect control products.
Receive News & Ratings for Dow Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical and related companies with MarketBeat.com's FREE daily email newsletter.